Logo image of CSAN

COSAN SA -ADR (CSAN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CSAN - US22113B1035 - ADR

4.04 USD
-0.16 (-3.81%)
Last: 12/19/2025, 8:04:00 PM
4.06 USD
+0.02 (+0.5%)
After Hours: 12/19/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, CSAN scores 4 out of 10 in our fundamental rating. CSAN was compared to 123 industry peers in the Specialty Retail industry. CSAN has a medium profitability rating, but doesn't score so well on its financial health evaluation. CSAN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CSAN had negative earnings in the past year.
CSAN had a positive operating cash flow in the past year.
CSAN had positive earnings in 4 of the past 5 years.
CSAN had a positive operating cash flow in each of the past 5 years.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

The Return On Assets of CSAN (-9.31%) is worse than 72.58% of its industry peers.
CSAN has a Return On Equity of -163.24%. This is in the lower half of the industry: CSAN underperforms 76.61% of its industry peers.
CSAN's Return On Invested Capital of 6.48% is fine compared to the rest of the industry. CSAN outperforms 62.90% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CSAN is significantly below the industry average of 12.18%.
The last Return On Invested Capital (6.48%) for CSAN is above the 3 year average (4.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROIC 6.48%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

CSAN has a Operating Margin of 20.98%. This is amongst the best in the industry. CSAN outperforms 98.39% of its industry peers.
CSAN's Operating Margin has declined in the last couple of years.
CSAN has a Gross Margin of 31.48%. This is in the lower half of the industry: CSAN underperforms 62.90% of its industry peers.
In the last couple of years the Gross Margin of CSAN has remained more or less at the same level.
Industry RankSector Rank
OM 20.98%
PM (TTM) N/A
GM 31.48%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSAN is destroying value.
The number of shares outstanding for CSAN has been reduced compared to 1 year ago.
The number of shares outstanding for CSAN has been increased compared to 5 years ago.
The debt/assets ratio for CSAN is higher compared to a year ago.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

CSAN has an Altman-Z score of 0.83. This is a bad value and indicates that CSAN is not financially healthy and even has some risk of bankruptcy.
CSAN has a worse Altman-Z score (0.83) than 73.39% of its industry peers.
The Debt to FCF ratio of CSAN is 17.68, which is on the high side as it means it would take CSAN, 17.68 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CSAN (17.68) is comparable to the rest of the industry.
A Debt/Equity ratio of 8.61 is on the high side and indicates that CSAN has dependencies on debt financing.
CSAN's Debt to Equity ratio of 8.61 is on the low side compared to the rest of the industry. CSAN is outperformed by 81.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Altman-Z 0.83
ROIC/WACC0.85
WACC7.62%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

CSAN has a Current Ratio of 1.83. This is a normal value and indicates that CSAN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.83, CSAN is in the better half of the industry, outperforming 78.23% of the companies in the same industry.
A Quick Ratio of 1.68 indicates that CSAN should not have too much problems paying its short term obligations.
CSAN has a Quick ratio of 1.68. This is amongst the best in the industry. CSAN outperforms 85.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.68
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

CSAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -872.35%.
Looking at the last year, CSAN shows a quite strong growth in Revenue. The Revenue has grown by 11.36% in the last year.
Measured over the past years, CSAN shows a very strong growth in Revenue. The Revenue has been growing by 26.51% on average per year.
EPS 1Y (TTM)-872.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-526.67%
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-8.43%

3.2 Future

Based on estimates for the next years, CSAN will show a very strong growth in Earnings Per Share. The EPS will grow by 35.46% on average per year.
CSAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.59% yearly.
EPS Next Y71.91%
EPS Next 2Y52.24%
EPS Next 3Y35.46%
EPS Next 5YN/A
Revenue Next Year-3.72%
Revenue Next 2Y-1.72%
Revenue Next 3Y0.03%
Revenue Next 5Y2.59%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSAN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 15.36, which indicates a correct valuation of CSAN.
Based on the Price/Forward Earnings ratio, CSAN is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, CSAN is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.36
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

CSAN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CSAN is cheaper than 77.42% of the companies in the same industry.
88.71% of the companies in the same industry are more expensive than CSAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.54
EV/EBITDA 6.1
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSAN's earnings are expected to grow with 35.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.24%
EPS Next 3Y35.46%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.44%, CSAN has a reasonable but not impressive dividend return.
The stock price of CSAN dropped by -28.62% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CSAN's Dividend Yield is rather good when compared to the industry average which is at 1.98. CSAN pays more dividend than 84.68% of the companies in the same industry.
CSAN's Dividend Yield is a higher than the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

On average, the dividend of CSAN grows each year by 25.09%, which is quite nice.
CSAN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)25.09%
Div Incr Years0
Div Non Decr Years0
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

CSAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CSAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-25.08%
EPS Next 2Y52.24%
EPS Next 3Y35.46%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

COSAN SA -ADR

NYSE:CSAN (12/19/2025, 8:04:00 PM)

After market: 4.06 +0.02 (+0.5%)

4.04

-0.16 (-3.81%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners10.43%
Inst Owner Change2.52%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.83B
Revenue(TTM)43.95B
Net Income(TTM)-11.74B
Analysts78.82
Price Target4.82 (19.31%)
Short Float %0.93%
Short Ratio5.25
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.43
Dividend Growth(5Y)25.09%
DP-25.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-812.09%
Min EPS beat(2)-1027.4%
Max EPS beat(2)-596.78%
EPS beat(4)0
Avg EPS beat(4)-744.76%
Min EPS beat(4)-1285.85%
Max EPS beat(4)-69.01%
EPS beat(8)1
Avg EPS beat(8)-367.61%
EPS beat(12)2
Avg EPS beat(12)-257.65%
EPS beat(16)4
Avg EPS beat(16)-198.12%
Revenue beat(2)0
Avg Revenue beat(2)-75.19%
Min Revenue beat(2)-76.92%
Max Revenue beat(2)-73.47%
Revenue beat(4)0
Avg Revenue beat(4)-74.24%
Min Revenue beat(4)-76.92%
Max Revenue beat(4)-72.24%
Revenue beat(8)0
Avg Revenue beat(8)-55.64%
Revenue beat(12)0
Avg Revenue beat(12)-51.45%
Revenue beat(16)0
Avg Revenue beat(16)-57.72%
PT rev (1m)-16.78%
PT rev (3m)-25.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-70.56%
EPS NY rev (1m)-7.19%
EPS NY rev (3m)-32.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.36
P/S 0.74
P/FCF 8.54
P/OCF 2.55
P/B 4.48
P/tB N/A
EV/EBITDA 6.1
EPS(TTM)-1.29
EYN/A
EPS(NY)0.26
Fwd EY6.51%
FCF(TTM)0.47
FCFY11.72%
OCF(TTM)1.58
OCFY39.17%
SpS5.46
BVpS0.9
TBVpS-2.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROCE 8.21%
ROIC 6.48%
ROICexc 7.59%
ROICexgc 10.52%
OM 20.98%
PM (TTM) N/A
GM 31.48%
FCFM 8.67%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
ROICexc(3y)5.12%
ROICexc(5y)5.21%
ROICexgc(3y)6.64%
ROICexgc(5y)7.56%
ROCE(3y)5.52%
ROCE(5y)5.33%
ROICexgc growth 3Y5.58%
ROICexgc growth 5Y-20.62%
ROICexc growth 3Y6.6%
ROICexc growth 5Y-13.61%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Debt/EBITDA 4.71
Cap/Depr 221.51%
Cap/Sales 20.32%
Interest Coverage 1.74
Cash Conversion 96.15%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.68
Altman-Z 0.83
F-Score6
WACC7.62%
ROIC/WACC0.85
Cap/Depr(3y)179.81%
Cap/Depr(5y)178.28%
Cap/Sales(3y)15.09%
Cap/Sales(5y)13.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-872.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-526.67%
EPS Next Y71.91%
EPS Next 2Y52.24%
EPS Next 3Y35.46%
EPS Next 5YN/A
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-8.43%
Revenue Next Year-3.72%
Revenue Next 2Y-1.72%
Revenue Next 3Y0.03%
Revenue Next 5Y2.59%
EBIT growth 1Y48.56%
EBIT growth 3Y24.77%
EBIT growth 5Y21.84%
EBIT Next Year102.33%
EBIT Next 3Y32.61%
EBIT Next 5Y17.37%
FCF growth 1Y-35.46%
FCF growth 3Y65.47%
FCF growth 5Y21.36%
OCF growth 1Y14.86%
OCF growth 3Y35.81%
OCF growth 5Y36.03%

COSAN SA -ADR / CSAN FAQ

What is the ChartMill fundamental rating of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSAN.


What is the valuation status of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a valuation rating of 5 / 10 to COSAN SA -ADR (CSAN). This can be considered as Fairly Valued.


Can you provide the profitability details for COSAN SA -ADR?

COSAN SA -ADR (CSAN) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CSAN stock?

The Earnings per Share (EPS) of COSAN SA -ADR (CSAN) is expected to grow by 71.91% in the next year.